SCHEMBL13219219

SCHEMBL13219219

COc1cc(OC)cc(S(=O)(=O)n2nc(CCC(=O)O)c3cc(OC)cnc32)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 2/20 0.40
▸ PPARD Q03181 2/20 0.40
▸ PPARA Q07869 2/20 0.40
▸ MTNR1A P48039 2/20 0.37
▸ KDM4E B2RXH2 3/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ HPGD P15428 3/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ PTGDR2 Q9Y5Y4 4/20 0.35
▸ POLB P06746 2/20 0.35
▸ ALKBH1 Q13686 1/20 0.35
▸ FFAR1 O14842 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ HTT P42858 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ RXRA P19793 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13219213 0.91 RXRA (0.42) PPARGPPARDPPARAMTNR1AKDM4E
SCHEMBL3034325 0.91 PPARG (0.51) PPARGPPARDPPARAALDH1A1HPGD
SCHEMBL13219212 0.85 PPARG (0.43) PPARGPPARDPPARAKDM4EALDH1A1
SCHEMBL13219234 0.82 FFAR1 (0.46) PPARGPPARDPPARAPOLBFFAR1
SCHEMBL13219211 0.82 TBXAS1 (0.42) PPARGPPARDPPARAPTGDR2MEN1
SCHEMBL13219235 0.81 FFAR1 (0.44) PPARGPPARDPPARAALDH1A1SMN1; SMN2
SCHEMBL13219232 0.81 ADAMTS4 (0.47) PPARGPPARDPPARAALDH1A1SMN1; SMN2
SCHEMBL13219225 0.78 MAPT (0.41) PPARGPPARDPPARAALDH1A1FFAR1
SCHEMBL13219227 0.78 LMNA (0.42) PPARGPPARDPPARAPTGDR2
SCHEMBL13219226 0.76 HDAC6 (0.43) POLBFFAR1MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367828-B2 PPAR active compounds PLEXXIKON INC. (US) 2013-02-05 — — US disclosed
US-8367828-B2 PPAR active compounds PLEXXIKON INC. (US) 2013-02-05 — — US disclosed
US-20100210036-A1 PPAR ACTIVE COMPOUNDS PLEXXIKON, INC. 2010-08-19 — — US disclosed
US-20100210036-A1 PPAR ACTIVE COMPOUNDS PLEXXIKON, INC. 2010-08-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210036-A1 PPAR ACTIVE COMPOUNDS PPARG, PPARD, PPARA PPARG 1/4885PPARD 2/4885PPARA 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback